Skip to Content

Resources

November 17, 2016

Insulin isn’t just a drug

By: alan-yatvin

Insulin isn’t just a drug.
Stand up for Affordable Insulin

Insulin isn’t just a drug. It’s the difference between life and death for millions of people with diabetes—and it’s something they will need every day for the rest of their lives.

When you or someone you love needs insulin and cannot afford it, the choices are scary. As the cost of insulin continues to rise, more of us, our family members, our friends and our neighbors are rationing their insulin or doing without other necessities to pay for this lifesaving drug.

This is unacceptable. It’s time to stand together and call for change.

The American Diabetes Association’s Board of Directors unanimously passed a resolution calling for immediate action by Congress and by all of the parties involved in the insulin supply chain to ensure affordable insulin for everyone who needs this lifesaving medication.

But to make sure that call is heard by those with the power to make a difference, we need you.

Add your name to the petition and join the Association to support those struggling with access to insulin.

Once you’ve signed on, help us spread the word. Real change can only happen when we raise our voices together. Here’s how you can help:

1.  Share the petition with your social media community. Tell them why it matters and invite them to join you in this fight.

2. Email your friends, family, neighbors, co-workers and classmates to tell them how important it is to keep insulin affordable, and ask them to add their voices to this call to action at stopdiabetes.com/insulin

3. Know other organizations that have a stake in making insulin affordable? Ask them to join us, and make this call for change even stronger.

Let’s send a message that the rising cost of insulin, and the lives of those who depend on it, cannot be ignored.

Alan L. Yatvin Member, Board of Directors American Diabetes Association

SIGN THE PETITION

Leaders of the Legal Profession

Sign up to receive email updates for Weir Greenblatt Pierce LLP